Anavex Life Sciences
AVXL
145 hedge funds and large institutions have $153M invested in Anavex Life Sciences in 2024 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 19 closing their positions.
66% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 29
35% more capital invested
Capital invested by funds: $113M → $153M (+$40.1M)
21% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 19
3% more funds holding
Funds holding: 141 → 145 (+4)
2% more call options, than puts
Call options by funds: $4.89M | Put options by funds: $4.79M
0.11% more ownership
Funds ownership: 31.71% → 31.82% (+0.11%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NL
NWAM LLC
Mercer Island,
Washington
|
+$5.25M |
| 2 |
BlackRock
New York
|
+$2.01M |
| 3 |
Millennium Management
New York
|
+$1.75M |
| 4 |
Morgan Stanley
New York
|
+$1.62M |
| 5 |
Goldman Sachs
New York
|
+$1.18M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$3.89M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$2.43M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.88M |
| 4 |
Renaissance Technologies
New York
|
-$1.28M |
| 5 |
Two Sigma Investments
New York
|
-$1.05M |
AVXL Hedge Fund Activity: Q3 2024 in Review
145 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q3 2024, worth a combined $153M — up 35% from $113M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new AVXL positions and 19 closed out — a net gain of 4 holders — while 48 added to existing stakes and 29 trimmed.
The largest buyer was NWAM LLC, opening a new position worth an estimated $5.25M. The largest seller was State Street, cutting an estimated $3.89M.
- 145 institutional investors held Anavex Life Sciences (AVXL) as of Q3 2024, up from 141 in Q2 2024.
- Funds reported $153M of Anavex Life Sciences stock for Q3 2024, up 35% quarter-over-quarter.
- 23 funds opened new Anavex Life Sciences positions in Q3 2024 and 19 closed out, a net change of +4 holders.
- The largest Anavex Life Sciences buyer in Q3 2024 was NWAM LLC, an estimated $5.25M added.
- The largest Anavex Life Sciences seller in Q3 2024 was State Street, an estimated $3.89M sold.
Based on aggregated 13F filings for Q3 2024.